Mary Frances McMullin

14.7k total citations · 2 hit papers
215 papers, 7.5k citations indexed

About

Mary Frances McMullin is a scholar working on Genetics, Hematology and Molecular Biology. According to data from OpenAlex, Mary Frances McMullin has authored 215 papers receiving a total of 7.5k indexed citations (citations by other indexed papers that have themselves been cited), including 132 papers in Genetics, 120 papers in Hematology and 86 papers in Molecular Biology. Recurrent topics in Mary Frances McMullin's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (111 papers), Acute Myeloid Leukemia Research (68 papers) and Kruppel-like factors research (48 papers). Mary Frances McMullin is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (111 papers), Acute Myeloid Leukemia Research (68 papers) and Kruppel-like factors research (48 papers). Mary Frances McMullin collaborates with scholars based in United Kingdom, United States and Germany. Mary Frances McMullin's co-authors include Claire Harrison, Melanie J. Percy, Terence R.J. Lappin, Anthony R. Green, Philip Beer, Alan K. Burnett, Robert K. Hills, Frank S. Lee, Ken Mills and Keith Wheatley and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Mary Frances McMullin

202 papers receiving 7.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

JAK2 Exon 12 Mutations in Polycythemia Vera and Idiopathic Erythrocytosis

2007 898 citations Linda M. Scott, Philip Beer et al. profile →
Arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia in all risk groups (AML17): results of a randomised, controlled, phase 3 trial

2015 346 citations Alan K. Burnett, Nigel H. Russell et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mary Frances McMullin United Kingdom	43	4.4k	4.2k	3.6k	1.5k	1.0k	215	7.5k
Matteo Giovanni Della Porta Italy	43	3.7k 0.8×	5.3k 1.3×	2.0k 0.6×	585 0.4×	425 0.4×	193	7.5k
Luca Malcovati Italy	47	3.8k 0.9×	5.9k 1.4×	2.1k 0.6×	396 0.3×	576 0.6×	187	7.5k
Norbert Gattermann Germany	44	3.7k 0.8×	5.6k 1.3×	2.1k 0.6×	1.1k 0.8×	239 0.2×	256	7.2k
Martha Wadleigh United States	38	4.7k 1.1×	5.3k 1.3×	3.5k 1.0×	1.8k 1.2×	306 0.3×	134	7.7k
Claire Harrison United Kingdom	58	12.8k 2.9×	9.4k 2.2×	7.7k 2.1×	5.1k 3.4×	341 0.3×	452	15.0k
Ilene Galinsky United States	32	1.9k 0.4×	3.3k 0.8×	2.6k 0.7×	495 0.3×	446 0.4×	84	5.3k
Rosangela Invernizzi Italy	31	2.4k 0.5×	3.7k 0.9×	1.5k 0.4×	297 0.2×	176 0.2×	157	5.2k
Carlo Aul Germany	42	3.5k 0.8×	8.6k 2.0×	2.6k 0.7×	193 0.1×	394 0.4×	150	9.5k
Ulrich Germing Germany	47	2.9k 0.6×	5.9k 1.4×	2.0k 0.6×	164 0.1×	284 0.3×	173	6.9k
Steven R. Zeldenrust United States	47	1.6k 0.4×	5.1k 1.2×	7.7k 2.1×	737 0.5×	138 0.1×	165	9.9k

Countries citing papers authored by Mary Frances McMullin

Since Specialization

Citations

This map shows the geographic impact of Mary Frances McMullin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Frances McMullin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Frances McMullin more than expected).

Fields of papers citing papers by Mary Frances McMullin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Frances McMullin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Frances McMullin. The network helps show where Mary Frances McMullin may publish in the future.

Co-authorship network of co-authors of Mary Frances McMullin

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Frances McMullin. A scholar is included among the top collaborators of Mary Frances McMullin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Frances McMullin. Mary Frances McMullin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Harrison, Claire, Sonia Fox, Rebecca H. Boucher, Mary Frances McMullin, & Adam J. Mead. (2024). Treatment of the blood cancer polycythemia vera with ruxolitinib in the MAJIC-PV study: a plain language summary. Future Oncology. 20(40). 3365–3376. 1 indexed citations

McMullin, Mary Frances & Claire Harrison. (2024). How I treat patients with low-risk polycythemia vera who require cytoreduction. Blood. 145(16). 1717–1723. 3 indexed citations

Ali, Ahlam, et al.. (2023). CD45 inhibition in myeloid leukaemia cells sensitizes cellular responsiveness to chemotherapy. Annals of Hematology. 103(1). 73–88. 3 indexed citations

Hindley, Andrew, et al.. (2020). Mutational profiling in suspected triple-negative essential thrombocythaemia using targeted next-generation sequencing in a real-world cohort. Journal of Clinical Pathology. 74(12). 808–811. 12 indexed citations

Burnett, Alan K., Nigel H. Russell, Robert K. Hills, et al.. (2020). Defining the Optimal Total Number of Chemotherapy Courses in Younger Patients With Acute Myeloid Leukemia: A Comparison of Three Versus Four Courses. Journal of Clinical Oncology. 39(8). 890–901. 19 indexed citations

McMullin, Mary Frances, Adam J. Mead, Sahra Ali, et al.. (2018). A guideline for the management of specific situations in polycythaemia vera and secondary erythrocytosis. British Journal of Haematology. 184(2). 161–175. 70 indexed citations

McMullin, Mary Frances, Claire Harrison, Catherine Cargo, et al.. (2018). A guideline for the diagnosis and management of polycythaemia vera. A British Society for Haematology Guideline. British Journal of Haematology. 184(2). 176–191. 94 indexed citations

Godfrey, Anna L., Peter J. Campbell, Cathy MacLean, et al.. (2017). Hydroxycarbamide Plus Aspirin Vs Aspirin Alone in Intermediate Risk Essential Thrombocythemia: Results of the PT-1 International, Prospective, Randomized Clinical Trial. Blood. 130. 319–319.

Camps, Carlos, Nayia Petousi, Celeste Bento, et al.. (2016). Gene panel sequencing improves the diagnostic work-up of patients with idiopathic erythrocytosis and identifies new mutations. Haematologica. 101(11). 1306–1318. 64 indexed citations

10.

Tefferi, Ayalew, Francesco Passamonti, Tiziano Barbui, et al.. (2013). Phase 3 Study Of Pomalidomide In Myeloproliferative Neoplasm (MPN)-Associated Myelofibrosis With RBC-Transfusion-Dependence. Blood. 122(21). 394–394. 24 indexed citations

11.

Furlow, Paul W., Melanie J. Percy, Charlene Bierl, et al.. (2009). Erythrocytosis-associated HIF-2α Mutations Demonstrate a Critical Role for Residues C-terminal to the Hydroxylacceptor Proline. Journal of Biological Chemistry. 284(14). 9050–9058. 42 indexed citations

12.

Elliott, Joanne, Yvonne Suessmuth, Latanya M. Scott, et al.. (2009). SOCS3 TYROSINE PHOSPHORYLATION AS A BIG-MARKER FOR THE MYELOPROLIFERATIVE DISORDER-ASSOCIATED MUTANT JAK2 KINASES. Haematologica. 94. 358–358. 1 indexed citations

13.

Percy, Melanie J., Philip Beer, Gavin Campbell, et al.. (2008). Novel exon 12 mutations in the HIF2A gene associated with erythrocytosis. Blood. 111(11). 5400–5402. 97 indexed citations

14.

Furlow, Paul W., et al.. (2007). A novel Arg371His mutation in the HIF prolyl hydroxylase PHD2 is associated with erythrocytosis. Haematologica. 92. 87–87. 1 indexed citations

15.

Percy, Melanie J., Mayka Sánchez, Sabina Świerczek, et al.. (2007). Is congenital secondary erythrocytosis/polycythemia caused by activating mutations within the HIF-2α iron-responsive element?. Blood. 110(7). 2776–2777. 3 indexed citations

16.

Scott, Linda M., et al.. (2007). JAK2 exon 12 mutations occur frequently in idiopathic erythrocytosis patients with low serum erythropoietin levels. Research Portal (Queen's University Belfast). 1 indexed citations

17.

Percy, Melanie J., Quan Zhao, Adrian Flores, et al.. (2006). A family with erythrocytosis establishes a role for prolyl hydroxylase domain protein 2 in oxygen homeostasis. Proceedings of the National Academy of Sciences. 103(3). 654–659. 252 indexed citations

18.

Percy, Melanie J., Mary Frances McMullin, Marilyn Treacy, et al.. (2002). Identification of the Chuvash-type congenital polycythemia in patients of Asian and western European ancestry.. Blood. 100. 1 indexed citations

19.

McMullin, Mary Frances, et al.. (1998). Homocysteine and methylmalonic acid as indicators of folate and vitamin B-12 deficiency in pregnancy.. British Journal of Haematology. 105. 73–73. 1 indexed citations

20.

Hull, David, et al.. (1996). Antineutrophil cytoplasmic antibodies in myelodysplasia. British Journal of Haematology. 93. 72–72. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact